Fierce Biotech Mix Logo.png Fierce Biotech Mix Logo.png
Webinar

Scaling Smarter, Not Harder: 4 Pillars for Successful Commercial Scale Manufacturing

ET
60 Minutes

Scaling to commercial manufacturing is one of the most critical—and challenging—phases in bringing a product to market. Missteps in scale-up and tech transfer can lead to costly delays, quality risks, and lost momentum.

Join LOTTE Biologics as we share the 4 Pillars we use to help clients achieve successful commercialization: Smart Scaling (choosing the right scale for your journey), Smart Transitions (creating a connected experience to derisk tech transfer), Smart Visibility (turning data into confidence), and  Smart Partnerships (growing together beyond manufacturing).

Through real-world insights, we'll show how our approach helps clients overcome common scaling and tech transfer pitfalls—from misaligned processes to communication gaps. Whether you're preparing for your first commercial launch or optimizing an existing manufacturing strategy, you'll leave with a clearer picture of what it takes to scale smarter, faster, and with greater confidence.
 

Speakers

0

Ryan Stelick

Snr Director, Manufacturing Operations
LOTTE Biologics

Ryan Stelick brings over 20 years of experience in biopharmaceutical manufacturing, spanning technical operations, quality, engineering, and commercial functions across both innovator organizations and LOTTE Biologics.

He currently leads manufacturing operations  across multiple modalities, driving operational excellence, customer satisfaction, workforce engagement, and business growth. His career progression from Production Operator to senior manufacturing leadership has given him a comprehensive understanding of the biopharmaceutical industry, with a proven record of delivering clinical and commercial therapies across mammalian cell culture, antibody-drug conjugate (ADC), and bioconjugation platforms.

Across his career, he has held leadership positions spanning the full biologics manufacturing lifecycle, including cell banking, drug substance production and fill, ADC manufacturing, manufacturing engineering, quality control laboratories, technical services, quality assurance, and product release. He is recognized for building and developing high-performing teams, aligning manufacturing performance with strategic business objectives.

Ryan Stelick holds a Bachelor of Science degree in Biological Sciences from SUNY Cortland.

0

Sunghwan Hong

Head of Upstream Manufacturing
LOTTE Biologics

Sunghwan Hong brings over 15 years of experience in biopharmaceutical manufacturing, spanning upstream process development, CDMO/CMC operations, technical operations, and organizational leadership within large-scale biologics manufacturing environments.

He currently serves as Upstream Team Lead, leading upstream process operations, resource planning, and strategic initiatives supporting site manufacturing goals. His experience also extends to Technical Operations, where he has contributed to GMP strategy documentation, client proposal responses, technology transfer and campaign readiness strategy, and the implementation of asset management systems.

Across his career, he has developed deep expertise across the full upstream manufacturing lifecycle, including cell line development, master cell banking, and process development using Quality by Design (QbD) principles. He has led upstream technology transfer efforts to external CMO/CDMO partners and supported specialty projects such as transient expression and toxicology batch production. His background also includes GMP manufacturing operations, equipment validation, and hands-on bioreactor management, alongside contributions to employee training and business strategy development.

Sunghwan Hong holds a Master's degree in Molecular Biology from Korea University and a Bachelor's degree in Biotechnology from Inha University.

Register here!

Already registered? Click here to login.
Date/Time:
ET